Raising a pre-seed round in medtech.
At pre-seed, medtech investors back a clinical need, an early prototype and a team that knows how devices reach patients. Here is what they look for and who writes the first checks.
Medtech
Medtech investors fund a device through three gates: a regulatory pathway, clinical evidence and a way to get paid. Your FDA route sets how much capital you need and how long it takes.
What pre-seed investors expect in medtech
There is no cleared device yet. Investors look at three things instead.
A clinical need, from clinicians
- A procedure or condition where current tools fall short
- Physicians who confirm the need in their own words
- Why a device, not a drug or software, is the answer
A working prototype
- Bench tests showing the core idea works
- Early design choices that keep manufacturing simple
- Patent filings on what makes it different
A first view of the pathway
- Your likely device class and FDA route
- Whether a similar device already exists to compare against
- A rough budget and timeline to clearance or approval
How the round comes together
Pre-seed medtech money often comes from physicians, grants and university programs.
- Angels and physicians
- Grants and university money
- Accelerators
Angels
Often leads
Physicians and device executives back founders solving problems they know.
Grants & non-dilutive
Often follows
Research and small-business grants fund prototypes and early testing.
University funds
Sometimes
Academic medical centers back devices invented by their clinicians.
Accelerators
Sometimes
Medtech programs add design, regulatory and clinical introductions.
Angel groups
Sometimes
Groups with many physician members regularly review device deals.
SAFE or priced round?
Most pre-seed medtech rounds are SAFEs or convertible notes. Device timelines are long, so notes may run longer than planned. Check maturity dates and what happens if you have not raised again.
The slides investors read first
Clinical need
The procedure, the patients and the gap.
Device
What it does and the bench data so far.
Pathway
Likely class, FDA route and timeline.
Team
Clinicians, engineers and device veterans.
The ask
Amount, instrument and the prototype it funds.
Questions founders ask
Do I need to know my FDA pathway before pre-seed?
You need a reasoned first view. Investors want to know whether you expect clearance against an existing device, a De Novo request or full approval, because each changes cost and timing.
Can grants fund a medtech prototype?
Often, yes. Research and small-business grants are a common way to fund early device work without dilution, though awards take months to arrive.
Sources
Sources: FDA guidance on device classification, 510(k), De Novo and PMA pathways; CMS coverage and coding resources; investors' published criteria. Editorial content, reviewed quarterly. Not financial, legal or medical advice.
Other stages
Related sectors
Who funds this round
Learn the terms
Run the numbers
Raise in your city
Inside Unicorn Factory
Free account
Investor matching is coming to your free account. Create it now and we will match your round the day it opens. Until then, get an honest read on your deck.